Table 3.
Comparison of plasma cMyBP-C levels with other biomarkers of MI. The values are expressed as mean values ± SEM values (ng/ml). Data show that plasma levels of cMyBP-C in patients with MI at base are significantly higher, compared to controls, for the selected 24 samples presenting high levels of cMyBP-C (>45.45 ng/mL)
| cMyBP-C (ng/ml) | cTnI (ng/ml) | CK-MB (ng/ml) | MYO (ng/ml) | GP-BB (ng/ml) | H-FABP (ng/ml) | CAIII (ng/ml) | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
| ||||||||||||||
| Control | Base (MI) | Control | Base (MI) | Control | Base (MI) | Control | Base (MI) | Control | Base (MI) | Control | Base (MI) | Control | Base (MI) | |
| Mean (ng/ml) | 18.51 ± 2.10 | 116.53 ± 13.32 | 0.19 ± 0.02 | 0.22 ± 0.01 | 0.66 ± 0.08 | 2.10 ± 0.4 | 6.09 ± 1.64 | 40.78 ± 5.13 | 6.11 ± 1.38 | 10.17 ± 1.46 | 1.97 ± 0.9 | 3.13 ± 0.46 | 4.40 ± 1.43 | 26.28 ± 4.61 |
| Fold change | 6.3 | 1.15 | 3.18 | 6.69 | 1.66 | 1.58 | 5.97 | |||||||
| P-value | <0.001 | 0.14 | 0.00 | <0.001 | 0.05 | 0.25 | <0.001 | |||||||
| Min (ng/ml) | 1.81 | 45.45 | 0.11 | 0.18 | 0.4 | 0.4 | 0.4 | 14.81 | 2.00 | 2.00 | 0.15 | 1.12 | 0.20 | 9.35 |
| Max (ng/ml) | 38.04 | 236.36 | 0.36 | 0.31 | 1.61 | 9.90 | 39.8 | 60.96 | 20.91 | 20.54 | 17.62 | 11.91 | 34.89 | 86.07 |
| n | 24 | 24 | 24 | 24 | 24 | 24 | 24 | 24 | 24 | 24 | 24 | 24 | 24 | 24 |